Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6819 (MIR6819) is a human microRNA—a small, non-coding RNA molecule involved in post-transcriptional regulation of gene expression. It acts primarily by binding to complementary sequences in target messenger RNAs (mRNAs), resulting in repression of translation or mRNA degradation[2][3][4]. MicroRNAs like MIR6819 are implicated in diverse biological processes, including immune responses, cell differentiation, and apoptosis, although the specific roles and validated targets of MIR6819 remain largely uncharacterized[4]. Preliminary studies have associated the circulating form, hsa-miR-6819-3p, with abnormal immune responses and post-exertional malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, suggesting possible biomarker potential[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6819 (MIR6819).